Mystic, CT, United States of America

Kendra Louise Nelson

USPTO Granted Patents = 5 


 

Average Co-Inventor Count = 9.0

ph-index = 3

Forward Citations = 57(Granted Patents)


Location History:

  • New London, CT (US) (2010)
  • Mystic, CT (US) (2011 - 2019)

Company Filing History:

goldMedal4 out of 4,455 
 
Pfizer Corporation
 patents
silverMedal1 out of 47 
 
Pfizer Products Inc.
 patents
bronzeMedal1 out of 832,880 
Other
 patents
where one patent can have more than one assignee

Years Active: 2010-2019

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Kendra Louise Nelson: Innovator in Pharmaceutical Chemistry

Introduction

Kendra Louise Nelson is a prominent inventor based in Mystic, CT (US). She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds for the treatment of abnormal cell growth.

Latest Patents

Kendra holds a total of 5 patents, with her latest inventions focusing on sulfonyl amide derivatives. These compounds are designed for the treatment of abnormal cell growth, including cancer, in mammals. The inventions detail a method of using these compounds in therapeutic applications, especially for humans, and include pharmaceutical compositions that incorporate these novel derivatives.

Career Highlights

Throughout her career, Kendra has worked with notable organizations, including Pfizer Corporation. Her work has been instrumental in advancing the understanding and treatment of various medical conditions through innovative chemical solutions.

Collaborations

Kendra has collaborated with esteemed colleagues such as Michael Luzzio and Samit Kumar Bhattacharya, contributing to a dynamic exchange of ideas and expertise in her field.

Conclusion

Kendra Louise Nelson's work exemplifies the impact of innovation in pharmaceutical chemistry, particularly in the fight against cancer. Her contributions continue to inspire advancements in medical treatments and research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…